News Sentiment

JSPR sentiment intelligence

Jasper Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 35 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.58 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 27

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+35.3% over one week, +26.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Jasper Therapeutics (NASDAQ: JSPR) sees Millennium group report 1.7% equity stake

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 35.3% Price confirming higher
Trend fit Trend inactive 26.6% over four weeks
Fair value -94.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 27
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 27
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
TradingView 4
simplywall.st 4
MT Newswires 3
GlobeNewswire 3
Stock Titan 2
Ad Hoc News 2
Investing.com 2

Event Lens

What the news is about

Classified themes
Market update 18
Earnings 10
Analyst action 4
Deals and strategy 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-35 of 35